regulatory status is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Updated 2026-07-05. Numbers and descriptions here follow the published literature rather than marketing material.
Cardarine is a common name for the investigational chemical GW501516, also written GW-1516. It was developed as a peroxisome proliferator-activated receptor delta agonist for metabolic conditions such as dyslipidemia. Early research focused on lipid handling and energy use in skeletal muscle and other tissues. The compound was never approved as a medicine. In public discussion, it is often grouped with performance-enhancing substances, although its receptor target differs from that of anabolic steroids or selective androgen receptor modulators. Regulatory and health authorities have issued warnings about its use.
GW501516 acts on PPARδ, a nuclear receptor that helps regulate fatty acid oxidation and energy homeostasis. In animal studies, activation of this receptor was associated with increased endurance and changes in lipid metabolism. Human trials examined effects on blood lipids and other metabolic markers, but the compound did not advance to approval. Rodent studies later reported tumors in multiple tissues at doses used in those experiments. Whether those findings translate to human risk remains uncertain, and the clinical relevance of the animal data is still debated.
Cardarine is a common name for GW501516, a synthetic compound studied for its effects on lipid and glucose metabolism. It functions as an agonist at peroxisome proliferator-activated receptor delta, or PPARδ, a nuclear receptor that influences gene expression. The molecule is not a steroid, nor is it a selective androgen receptor modulator. It is also known in research and sports literature as GW-501516 and endurobol. Early laboratory work examined its metabolic activity in cell cultures and animal models.
Activation of PPARδ changes transcription of genes involved in fatty acid transport, mitochondrial function, and skeletal muscle fuel preference. In rodent studies, pharmacological PPARδ activation was associated with increased endurance and altered body composition. These findings generated interest in performance enhancement, but species differences and study designs limit direct extrapolation to humans. Small human trials were conducted in the 2000s and later discontinued. The extent to which cardarine produces similar metabolic or performance effects in people remains an open question.
The compound is typically described as a laboratory compound rather than a therapeutic product. Published reports have explored its role in lipid disorders, insulin sensitivity, and exercise metabolism, yet no major drug regulator has approved it for medical use. Commercial samples sold under the cardarine name may vary in purity and identity. Analytical confirmation is therefore necessary when the material is discussed in scientific or regulatory contexts. Its classification as a prohibited substance in sport further shapes how it is studied and reported.
| Property | Value | Notes |
|---|---|---|
| Common name | Cardarine | Common internet and media name. |
| Research code | GW501516 | Also written GW-1516. |
| Drug class | PPARδ agonist | Not a selective androgen receptor modulator. |
| Development status | Discontinued | Clinical development halted after rodent cancer findings. |
| Regulatory status | Prohibited in sport | Listed by WADA; not approved as medicine. |
Cardarine is a common name for GW501516, a synthetic compound first described in the 1990s as a selective agonist of the peroxisome proliferator-activated receptor delta. It was studied in preclinical models for metabolic and cardiovascular conditions, but it has not been approved as a medicine in the United States, Europe, or other major jurisdictions. Retail products labeled as cardarine are generally research chemicals or supplements, not pharmaceutical formulations. Because human safety and efficacy data remain limited, regulatory agencies treat it as an unapproved substance rather than a therapeutic product.
Sporting authorities added GW501516 to prohibited lists after it appeared in athlete samples and online markets. The World Anti-Doping Agency classifies it as a hormone and metabolic modulator, and its use can lead to an anti-doping rule violation. Some early laboratory work suggested effects on fatty acid oxidation and endurance-related metabolism in animals, but those findings do not establish safe or effective use in people. Reports of adverse events in humans are scarce and often anecdotal, which complicates risk assessment.
Analytical laboratories typically identify cardarine and its metabolites using liquid chromatography-tandem mass spectrometry. Urine is a common matrix in anti-doping testing, while blood and tissue may be used in research settings. Detection windows depend on the assay, the sample matrix, and the compound's metabolism. Because cardarine is extensively metabolized, laboratories often target specific metabolites to improve sensitivity and confirmation. Reference standards are required for reliable quantification. Method validation includes checks for selectivity, linearity, and carryover.
A persistent misconception is that cardarine is a fat-burning drug or a safe alternative to anabolic steroids. No approved therapeutic product exists, and human safety data are limited. The tumor findings in rodents remain a central concern in scientific reviews. Products sold online may contain inaccurate labels, impurities, or different compounds entirely, which complicates any assessment of effects. Independent testing of such products has reported frequent mislabeling. For these reasons, discussions in the literature emphasize risks and unknowns rather than benefits.
The digital signal is transmitted using OFDM with the HDC (High-Definition Coding) proprietary audio compression format. HDC is based on, but not compatible with, the MPEG-4 standard HE-AAC. It uses a modified discrete cosine transform (MDCT) audio data compression algorithm. Digital Radio Mondiale (DRM) is a competing digital terrestrial radio standard developed mainly by broadcasters as a higher spectral efficiency replacement for legacy AM and FM broadcasting. Mondiale means "worldwide" in French and Italian; DRM was developed in 2001, and is currently supported by 23 countries, and adopted by some European and Eastern broadcasters beginning in 2003. The DRM30 mode uses the commercial broadcast bands below 30 MHz, and is intended as a replacement for standard AM broadcast on the longwave, mediumwave, and shortwave bands. The DRM+ mode uses VHF frequencies centered around the FM broadcast band, and is intended as a replacement for FM broadcasting. It is incompatible with existing radio receivers, so it requires listeners to purchase a new DRM receiver. The modulation used is a form of OFDM called COFDM in which, up to 4 carriers are transmitted on a channel formerly occupied by a single AM or FM signal, modulated by quadrature amplitude modulation (QAM). The DRM system is designed to be as compatible as possible with existing AM and FM radio transmitters, so that much of the equipment in existing radio stations can continue in use, augmented with DRM modulation equipment.
primary structure The first order of complexity of structural organization exhibited by a polypeptide or protein molecule, or by a polynucleotide or nucleic acid molecule; i.e. the specific linear sequence of amino acid residues, or of nucleotides, without regard to their spatial arrangement or conformation or any higher-order structure (either secondary, tertiary, or quartenary) the molecule might assume. By convention, the primary structure of a polypeptide is reported from the amino (N)-terminus to the carboxyl (C)-terminus, and the primary structure of a nucleic acid is reported from the 5'-end to the 3'-end.
In January 2001, Lee, Lifeson, and Peart came together to attempt to reassemble the band. According to Peart, "We laid out no parameters, no goals, no limitations, only that we would take a relaxed, civilized approach to the project." With the help of producer Paul Northfield, the band produced seventy-four minutes of music for their new album Vapor Trails, which was written and recorded in Toronto. Vapor Trails marked the first Rush studio recording to not include any keyboards or synthesizers since Caress of Steel. According to the band, the album's developmental process was extremely taxing and took approximately 14 months to finish, the longest they had ever spent writing and recording a studio album. Vapor Trails was released on May 14, 2002; to herald the band's comeback, the single and lead track from the album, "One Little Victory", was designed to grab the attention of listeners with its rapid guitar and drum tempos. The album was supported by the band's first tour in six years, including first-ever concerts in Brazil and Mexico City, where they played to some of the largest crowds of their career. The largest was a capacity crowd of 60,000 in São Paulo. Vapor Trails peaked at No. 3 in Canada and No. 6 in the US, while selling disappointingly in the UK, where it peaked at No. 38.
Sources: en.wikipedia.org
Carry messages between neurons via influence on the postsynaptic membrane. Have little or no effect on membrane voltage, but have a common carrying function such as changing the structure of the synapse. Communicate by sending reverse-direction messages that affect the release or reuptake of transmitters. The anatomical localization of neurotransmitters is typically determined using immunocytochemical techniques, which identify the location of either the transmitter substances themselves or of the enzymes that are involved in their synthesis. Immunocytochemical techniques have also revealed that many transmitters, particularly the neuropeptides, are co-localized, that is, a neuron may release more than one transmitter from its synaptic terminal. Various techniques and experiments such as staining, stimulating, and collecting can be used to identify neurotransmitters throughout the central nervous system.
=== Acute === According to the EPS, chlorothalonil is a toxicity category I eye irritant, producing severe eye irritation. It is in toxicity category II, "moderately toxic", if inhaled (inhaled LD50 0.094 mg/L in rats.) For skin contact and ingestion, chlorothalonil is rated toxicity category IV, "practically nontoxic", meaning the oral and dermal LD50 is greater than 10,000 mg/kg.
Compared to the Basic Test it is more sensitive to operator technique, and as a result may be less precise. Acute Toxicity Solid-Phase Test is a procedure that allows the test organism to come in direct contact with the solid sample as particulate in an aqueous suspension. Normally, this test provides results indicating equal or higher toxicity when compared to eluate or pore water tests of the same sample. This is due to either equal or increased bioavailability resulting from direct contact. This test is subject to several sources of interference of luminescence including loss of bacteria from effects other than toxicity such as filtration of the sample; absorption of light due to color; and scattering of light due to turbidity. Corrections can be made by testing a sample of similar particle composition that is known to not be toxic. This test consists of two controls and 13 sample dilutions in duplicate. The Solid-Phase Test exposes the bacteria in such a way that is not always possible with pore water and elutriate. Acute Toxicity Comparison & Inhibition Tests are the best procedures for testing samples with a low level of toxicity when an ECxx can not be determined using the Basic Test. These protocols are recommended for testing waste water treatment plant effluent, stormwater runoff, drinking water, pore water, and eluate. These tests use multiple replicates of a sample at a single concentration. Similar to the Basic Test, the Comparison Test protocol uses zero time light readings used for correcting the timed light level readings.
Sources: en.wikipedia.org
Radon is a member of the zero-valence elements that are called noble gases, and is chemically not very reactive. The inert pair effect stabilizes the 6s shell, making it unavailable for bonding—a consequence only understood within relativistic quantum chemistry. The 3.8-day half-life of 222Rn makes it useful in physical sciences as a natural tracer. Because radon is a gas at standard conditions, unlike its decay-chain parents, it can readily be extracted from them for research. It is inert to most common chemical reactions, such as combustion, because the outer valence shell contains eight electrons. This produces a stable, minimum energy configuration in which the outer electrons are tightly bound. Its first ionization energy—the minimum energy required to extract one electron from it—is 1037 kJ/mol. In accordance with periodic trends, radon has a lower electronegativity than the element one period before it, xenon, and is therefore more reactive. Early studies concluded that the stability of radon hydrate should be of the same order as that of the hydrates of chlorine (Cl2) or sulfur dioxide (SO2), and significantly higher than the stability of the hydrate of hydrogen sulfide (H2S). Because of its cost and radioactivity, experimental chemical research is seldom performed with radon, and as a result there are very few reported compounds of radon, all either fluorides or oxides. Radon can be oxidized by powerful oxidizing agents such as fluorine, thus forming radon difluoride (RnF2).
== Signs and symptoms == People with antidepressant discontinuation syndrome have been on an antidepressant for at least four weeks and have recently stopped taking the medication, whether abruptly, after a fast taper, or each time the medication is reduced on a slow taper. Commonly reported symptoms include flu-like symptoms (e.g., nausea, vomiting, diarrhea, headaches, sweating) and sleep disturbances (e.g., insomnia, nightmares, constant sleepiness). Sensory and movement disturbances have also been reported, including imbalance, tremors, vertigo, dizziness, and electric-shock-like experiences in the brain, often described by people who have them as brain zaps. These "brain zaps" have been described as an electric shock felt in the skull, potentially triggered by lateral eye movement, and at times accompanied by vertigo, pain, or dissociative symptoms. Some individuals consider it as a pleasant experience akin to an orgasm, however it is more often reported as an unpleasant experience that interferes with daily function. Mood disturbances such as dysphoria, anxiety, or agitation are also reported, as are cognitive disturbances such as confusion and hyperarousal. In cases associated with sudden discontinuation of MAO inhibitors (MAOIs), acute psychosis has been observed. Over fifty symptoms have been reported. The SNRI venlafaxine has been reported to have a higher incidence in withdrawal symptoms after discontinuation when compared to other SNRIs. Venlafaxine has also been implicated to create withdrawal symptoms regardless of dosage.
Kort & Ricker (2026) compare pelvic morphology of Sinopa and Thinocyon with those of extant mammals, and argue that extant carnivorans might be imperfect analogs for reconstructions of configuration of musculature and locomotor modes of hyaenodonts. Fischer et al. (2026) study the body mass evolution in European mesonychians, hyaenodonts, oxyaenodonts and carnivoramorphs during the Paleogene, reporting evidence of increase of range of body mass of members of Carnivoramorpha after the Middle Eocene Climatic Optimum (and before the establishment of carnivoran-dominated faunas related to the Grande Coupure), and interpret the replacement of hyaenodont-dominated faunas in Europe by carnivoran-dominated ones as more likely related to climate changes than caused by competition between the different group of mammalian carnivores.
The initial contact between macrophage antigen-bound MHC II and TCR serves as the contact point between the two cells where most of the IFN-γ secretion and CD-40L on T cells concentrate to, so only macrophages directly interacting with TH1 cells are likely to be activated. In addition to activating M1 macrophages, TH1 cells express Fas ligand (FasL) and lymphotoxin beta (LT-β) to help kill chronically infected macrophages that can no longer kill pathogens. The killing of chronically infected macrophages release pathogens to the extracellular space that can then be killed by other activated macrophages. TH1 cells also help recruit more monocytes, the precursor to macrophages, to the infection site. TH1 secretion TNF-α and LT-α to make blood vessels easier for monocytes to bind to and exit. TH1 secretion of CCL2 as a chemoattractant for monocytes. IL-3 and GM-CSF released by TH1 cells stimulate more monocyte production in the bone marrow. When intracellular pathogens cannot be eliminated, such as in the case of Mycobacterium tuberculosis, the pathogen is contained through the formation of granuloma, an aggregation of infected macrophages surrounded by activated T cells. The macrophages bordering the activated lymphocytes often fuse to form multinucleated giant cells that appear to have increased antimicrobial ability due to their proximity to TH1 cells, but over time, the cells in the center start to die and form necrotic tissue.
Sources: en.wikipedia.org
No. Cardarine is a PPARδ agonist, while selective androgen receptor modulators act on androgen receptors. The two classes differ in receptor target and downstream effects.
Preclinical rodent studies reported cancers, including liver and bladder tumors, at tested doses. The human relevance of those findings is uncertain, but development was discontinued. No approved human product resulted.
No. It remains an investigational compound without approved therapeutic labeling. Sports regulators prohibit its use, and health agencies have warned against consuming it.
Cardarine is a common name for GW501516, a synthetic PPARδ agonist. It is not a steroid or a selective androgen receptor modulator. It was developed and studied as a research compound for metabolic pathways.